EORTC Study 26041-22041: Phase I/II study on concomitant and adjuvant temozolomide (TMZ) and radiotherapy (RT) with or without PTK787/ZK222584 (PTK/ZK) in newly diagnosed glioblastoma-Results of a phase I trial

Brandes, A. A. and Stupp, R. and Hau, P. and Sleijfer, S. and Lacombe, D. and Gorlia, T. and Yun, H. and Tosoni, A. and Mirimanoff, R. and van den Bent, M. J. (2007) EORTC Study 26041-22041: Phase I/II study on concomitant and adjuvant temozolomide (TMZ) and radiotherapy (RT) with or without PTK787/ZK222584 (PTK/ZK) in newly diagnosed glioblastoma-Results of a phase I trial. JOURNAL OF CLINICAL ONCOLOGY, 25 (18supp): 2026. ISSN 0732-183X, 1527-7755

Full text not available from this repository.
Item Type: Article
Subjects: 600 Technology > 610 Medical sciences Medicine
Divisions: Medicine > Lehrstuhl für Neurologie
Medicine > Zentren des Universitätsklinikums Regensburg > Zentrum für Hirntumore (ZHT)
Depositing User: Petra Gürster
Date Deposited: 30 Oct 2020 09:13
Last Modified: 30 Oct 2020 09:13
URI: https://pred.uni-regensburg.de/id/eprint/32600

Actions (login required)

View Item View Item